Aster Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.57K Buy
100
+78
+355% +$2.06K ﹤0.01% 888
2026
Q2
$557 Buy
+22
New +$501 ﹤0.01% 804
2026
Q1
– Sell
-1,085
Closed -$23.2K – 1141
2025
Q4
$23.2K Buy
+1,085
New +$22.2K 0.01% 608
2025
Q1
– Sell
-599
Closed -$7.86K – 1512
2024
Q4
$7.86K Sell
599
-111
-16% -$1.53K ﹤0.01% 805
2024
Q3
$8.23K Buy
+710
New +$6.7K ﹤0.01% 836

Other funds holding MD

Aster Capital Management's MD Position: Q3 2026 in Review

Aster Capital Management increased its Pediatrix Medical (MD) stake by 355% in Q3 2026, buying an estimated $2.06K and bringing the position to 100 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Aster Capital Management first reported a position in MD in Q3 2024 and has held it in 5 quarters since. The position peaked at $23.2K in Q4 2025. 205 funds tracked by Wall St. Rank hold MD as of Q3 2026.

  • Aster Capital Management held 100 shares of Pediatrix Medical worth $2.57K as of Q3 2026.
  • Aster Capital Management bought 78 Pediatrix Medical shares in Q3 2026, an estimated $2.06K.
  • Pediatrix Medical made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #888 holding.
  • Aster Capital Management first reported a position in Pediatrix Medical in Q3 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Pediatrix Medical position peaked at $23.2K in Q4 2025.
  • 205 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.